Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial-Reference-Cited by-同舟云学术

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Published:2002-11 Issue:9346 Volume:360 Page:1623-1630
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Shepherd James,Blauw Gerard J,Murphy Michael B,Bollen Edward LEM,Buckley Brendan M,Cobbe Stuart M,Ford Ian,Gaw Allan,Hyland Michael,Jukema J Wouter,Kamper Adriaan M,Macfarlane Peter W,Meinders A Edo,Norrie John,Packard Chris J,Perry Ivan J,Stott David J,Sweeney Brian J,Twomey Gillian,Westendorp Rudi GJ

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N EnglJ Med,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS Airforce/Texas Coronary Atherosclerosis Prevention Study;Downs;JAMA,1998

5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N Engl J Med,1998

Cited by 2920 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low LDL-C: Is It all Good News?;Current Atherosclerosis Reports;2024-09-10

2. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

3. Patterns of Statin Therapy Use and Associated Outcomes in Older Veterans Across Kidney Function;The American Journal of Medicine;2024-09

4. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials;Atherosclerosis;2024-09

5. Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I;Atherosclerosis;2024-09